These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 33566707

  • 1. Management of irritable bowel syndrome with diarrhea: focus on eluxadoline.
    Jones J, Lembo A, Heidelbaugh J, Kuritzky L, Lacy B.
    Curr Med Res Opin; 2021 Apr; 37(4):567-578. PubMed ID: 33566707
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.
    Nee J, Zakari M, Lembo AJ.
    Expert Opin Pharmacother; 2015 Apr; 16(18):2781-92. PubMed ID: 26558923
    [Abstract] [Full Text] [Related]

  • 6. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
    Cash BD, Lacy BE, Rao T, Earnest DL.
    Expert Opin Pharmacother; 2016 Apr; 17(3):311-22. PubMed ID: 26559529
    [Abstract] [Full Text] [Related]

  • 7. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea.
    Brenner DM, Sayuk GS.
    Adv Ther; 2020 Jan; 37(1):83-96. PubMed ID: 31707713
    [Abstract] [Full Text] [Related]

  • 8. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.
    Lacy BE.
    Neurogastroenterol Motil; 2016 Jan; 28(1):26-35. PubMed ID: 26690872
    [Abstract] [Full Text] [Related]

  • 9. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide.
    Brenner DM, Sayuk GS, Abel JL, Burslem K.
    J Manag Care Spec Pharm; 2021 Apr; 27(4):469-477. PubMed ID: 33769858
    [Abstract] [Full Text] [Related]

  • 10. Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
    Lacy BE, Chey WD, Cash BD, Lembo AJ, Dove LS, Covington PS.
    Am J Gastroenterol; 2017 Jun; 112(6):924-932. PubMed ID: 28417992
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea.
    Cash BD, Lacy BE, Schoenfeld PS, Dove LS, Covington PS.
    Am J Gastroenterol; 2017 Feb; 112(2):365-374. PubMed ID: 27922029
    [Abstract] [Full Text] [Related]

  • 13. The place of eluxadoline in the management of irritable bowel syndrome with diarrhea.
    Levio S, Cash BD.
    Therap Adv Gastroenterol; 2017 Sep; 10(9):715-725. PubMed ID: 28932272
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome.
    Scarpellini E, Laterza L, Ianiro G, Tack J, Abenavoli L, Gasbarrini A.
    Expert Opin Pharmacother; 2016 Jul; 17(10):1395-402. PubMed ID: 27267380
    [Abstract] [Full Text] [Related]

  • 16. Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome.
    Keating GM.
    Drugs; 2017 Jun; 77(9):1009-1016. PubMed ID: 28493170
    [Abstract] [Full Text] [Related]

  • 17. Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.
    Özdener AE, Rivkin A.
    Drug Des Devel Ther; 2017 Jun; 11():2827-2840. PubMed ID: 29033544
    [Abstract] [Full Text] [Related]

  • 18. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
    Abel JL, Carson RT, Andrae DA.
    Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Diarrhea.
    Lembo A, Sultan S, Chang L, Heidelbaugh JJ, Smalley W, Verne GN.
    Gastroenterology; 2022 Jul; 163(1):137-151. PubMed ID: 35738725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.